Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.
Deyell MW, Steinberg C, Doucette S, Parkash R, Nault I, Gray C, Essebag V, Gardner M, Sterns LD, Healey JS, Hruczkowski T, Rivard L, Leong-Sit P, Nery PB, Sapp JL.
Deyell MW, et al. Among authors: steinberg c.
J Cardiovasc Electrophysiol. 2018 Apr;29(4):603-608. doi: 10.1111/jce.13431. Epub 2018 Feb 1.
J Cardiovasc Electrophysiol. 2018.
PMID: 29356207
Clinical Trial.